|Mr. Peter Crock M.B.A., MBA||Chief Exec. Officer||336.87k||N/A||N/A|
|Ms. Deborah Ambrosini B.Com., F.C.A.||CFO & Company Sec.||255.03k||N/A||1974|
|Mr. Shane Duncan||Chief Operating Officer||301.17k||N/A||N/A|
|Mr. Geoff Aldred||Chief Projects & Information Officer||N/A||N/A||N/A|
|Mr. Clive Fanning||Head of Investor Relations||N/A||N/A||N/A|
|Mr. Steven Notaro||Head of Legal||N/A||N/A||N/A|
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.
Cann Group Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.